Research Topics
Species | Marc A Dall'EraSummaryAffiliation: University of California Country: USA Publications
| Collaborators
|
Detail Information
Publications
Differential expression of CD10 in prostate cancer and its clinical implicationMarc A Dall'Era
Department of Urology, University of Washington, Seattle, WA, USA
BMC Urol 7:3. 2007..We hypothesize that prostate tumors expressing high levels of CD10 have a more aggressive biology with an early propensity towards lymph node metastasis...
Active surveillance for low-risk prostate cancer: selection of patients and predictors of progressionMarc A Dall'Era
Department of Urology, University of California, San Francisco, CA 94143 1695, USA
Nat Clin Pract Urol 5:277-83. 2008..The psychosocial impact of active surveillance on patients is discussed as well as contemporary methods for disease monitoring...
Active surveillance for early-stage prostate cancer: review of the current literatureMarc A Dall'Era
Department of Urology, University of California at San Francisco Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California 94143 1695, USA
Cancer 112:1650-9. 2008..The best candidates for active surveillance are being defined, as are predictors of active treatment. The psychosocial ramifications of surveillance for prostate cancer can be profound and future needs and unmet goals will be discussed...
HSP27 and HSP70 interact with CD10 in C4-2 prostate cancer cellsMarc A Dall'Era
Department of Urology, University of Washington, Seattle, Washington, USA
Prostate 67:714-21. 2007..In this study, we compared CD10 mRNA and protein expression between benign and malignant prostate cells and employed proteomic analysis to identify proteins that interact with CD10 in C4-2 prostate cancer cells...
Active surveillance for the management of prostate cancer in a contemporary cohortMarc A Dall'Era
Department of Urology and the Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California 94143 1695, USA
Cancer 112:2664-70. 2008..In this article, the authors report their experience in a contemporary cohort of men with prostate cancer who were managed with active surveillance...
Urethrectomy following cystectomy for bladder cancer in men: practice patterns and impact on survivalJason L Nelles
University of California San Francisco, San Francisco, California 94143, USA
J Urol 180:1933-6; discussion 1936-7. 2008..We describe the frequency of urethrectomy by bladder cancer stage and identify clinical characteristics that predict urethrectomy. We also investigated whether urethrectomy offers any additional independent survival benefit...
Surgical management after active surveillance for low-risk prostate cancer: pathological outcomes compared with men undergoing immediate treatmentMarc A Dall'Era
Department of Urology, University of California, Davis, Sacramento, CA 95817, USA
BJU Int 107:1232-7. 2011....
Economic analysis of active surveillance for localized prostate cancerSun Kim
Department of Urology, School of Medicine, University of California, Davis, California, USA
Curr Opin Urol 22:247-53. 2012..The purpose of this review is to analyze the economics of active surveillance in comparison with other therapies...
Active surveillance for prostate cancer: a systematic review of the literatureMarc A Dall'Era
Department of Urology, University of California Davis Medical Center, Sacramento, CA 95817, USA
Eur Urol 62:976-83. 2012..Prostate cancer (PCa) remains an increasingly common malignancy worldwide. The optimal management of clinically localized, early-stage disease remains unknown, and profound quality of life issues surround PCa interventions...
Comparison of the incidence of latent prostate cancer detected at autopsy before and after the prostate specific antigen eraBadrinath R Konety
Department of Urology, University of Iowa, Iowa City, Iowa 52242, USA
J Urol 174:1785-8; discussion 1788. 2005..To determine if significant differences exist in the prevalence of latent prostate cancer between periods before and after the advent of screening for prostate cancer, we compared 2 groups of men undergoing autopsy during the 2 periods...
Does the interval between prostate biopsy and radical prostatectomy affect the immediate postoperative outcome?Daniel K Lee
Department of Urology, University of Iowa, Iowa City, IA, USA
BJU Int 97:48-50. 2006..To determine whether the interval between prostate biopsy and radical prostatectomy (RP) affects the immediate postoperative outcome...
Analysis of complications following partial and total nephrectomy for renal cancer in a population based sampleFadi N Joudi
Department of Urology, University of Iowa, Iowa City, Iowa, USA
J Urol 177:1709-14. 2007..We determined the frequency and predictors of complications of partial and total nephrectomy in a population based sample...
Watchful waiting versus active surveillance: appropriate patient selectionMarc A Dall'Era
Division of Urology, University of California, San Diego, UCSD Medical Center, 200 West Arbor Drive 8897, San Diego, CA 92103, USA
Curr Urol Rep 9:211-6. 2008..Finally, we support well-designed prospective clinical trials that evaluate active surveillance compared with immediate definitive treatment...
Screening and management of prostate cancer in elderly men: the Iowa Prostate Cancer ConsensusBadrinath R Konety
University of Iowa Department of Urology, Iowa City, Iowa, USA
Urology 71:511-4. 2008..Because there are no currently established guidelines for screening and management of prostate cancer in elderly men (older than 75 years), a multidisciplinary panel was convened to develop consensus recommendations...
Factors affecting outcomes after radical cystectomy in African AmericansBadrinath R Konety
Department of Urology, University of California San Francisco, San Francisco, California 94143 1695, USA
Cancer 109:542-8. 2007..The authors hypothesized that differences in hospital volume where patients undergo radical cystectomy may be responsible for race-based differences in outcomes after the procedure...
Complications rates of non-oncologic urologic procedures in population-based data: a comparison to published seriesDavid S Aaronson
Department of Urology, University of California San Francisco, San Francisco, CA 94117, USA
Int Braz J Urol 36:548-56. 2010..We sought to compare complication and mortality rates following urologic procedures derived from population-based data to those of published single-institutional case series...
Mortality after major surgery for urologic cancers in specialized urology hospitals: are they any better?Badrinath R Konety
Department of Urology, Carver College of Medicine and College of Public Health, University of Iowa, Iowa City, IA, USA
J Clin Oncol 24:2006-12. 2006..We sought to determine whether a high volume of unrelated complex procedures or procedures in the same specialty area (urology) could translate into better outcomes after major urologic cancer surgery...
Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomesPiyush K Agarwal
Department of Urology, Case Western Reserve University School of Medicine and University Hospitals Case Medical Center, Cleveland, Ohio, USA
Cancer 112:307-14. 2008..The authors report the likelihood of treatment failure and the outcomes after salvage therapy among men with prostate cancer who initially either received external-beam radiation therapy (EBRT) or underwent radical prostatectomy (RP)...
Complications after radical cystectomy: analysis of population-based dataBadrinath R Konety
Department of Urology, University of California, San Francisco, School of Medicine, UCSF Mt Zion Medical Center, San Francisco, California 94143 1695, USA
Urology 68:58-64. 2006..Complications after radical cystectomy have been reported from large single-institution series but population-based representative data are lacking...
Bladder and upper tract urothelial cancerBadrinath R Konety
Department of Urology, University of California San Francisco, San Francisco, CA 94143 1695, USA
J Urol 177:1636-45. 2007..We quantified the economic impact of caring for patients with bladder and upper tract urothelial cancer, and determined the primary drivers for such costs in the population in the United States...
Should men over the age of 65 years receive PSA screening? Argument in favorJared M Whitson
Department of Urology, University of California San Francisco, San Francisco, CA 94143, USA
Nat Clin Pract Urol 5:230-1. 2008
PSA screening among elderly men with limited life expectanciesLouise C Walter
Division of Geriatrics, San Francisco VA Medical Center, California, San Francisco 94121, USA
JAMA 296:2336-42. 2006..However, there are no large-scale studies of actual PSA screening practices in elderly men, according to life expectancy...
Practice patterns in screening and management of prostate cancer in elderly menBadrinath R Konety
Department of Urology, University of Iowa, Iowa City, Iowa, USA
Urology 68:1051-6. 2006..To determine the practice preferences for prostate cancer screening and treatment in men 75 years of age or older among healthcare providers in Iowa...
Patterns of primary and secondary therapy for prostate cancer in elderly men: analysis of data from CaPSUREBadrinath R Konety
Department of Urology and Comprehensive Cancer Center, University of California San Francisco, San Francisco, California 94143 1695, USA
J Urol 179:1797-803; discussion 1803. 2008..We examined patterns of primary treatment for prostate cancer in men 75 years or older...
Meta-analysis: does lidocaine gel before flexible cystoscopy provide pain relief?David S Aaronson
UCSF Medical Center, Department of Urology, Ambulatory Care Center, Suite A633, San Francisco, CA 94117, USA
BJU Int 104:506-9; discussion 509-10. 2009....
Effect of uniform consensus recommendations for PCa screening in older population: differential effects and perceptions of healthcare providers and patientsBadrinath R Konety
Department of Urology, University of California, San Francisco, School of Medicine, San Francisco, California 94143, USA
Urology 73:603-8; discussion 608-9. 2009..We also surveyed healthcare providers and men >75 years old to determine whether provider attitudes toward continued PCa screening in older men had changed...
Recovery of urinary continence following radical prostatectomy: the impact of prostate volume--analysis of data from the CaPSURE DatabaseBadrinath R Konety
Department of Urology, University of California San Francisco and University of California San Francisco Comprehensive Cancer Center, San Francisco, California 94143, USA
J Urol 177:1423-5; discussion 1425-6. 2007..We determined if prostate volume determined by preoperative transrectal ultrasound could predict recovery of urinary function and continence following radical prostatectomy...
In vivo tumor grading of prostate cancer using quantitative 111In-capromab pendetide SPECT/CTYoungho Seo
Department of Radiology and Biomedical Imaging, University of California, San Francisco, California 94143 0946, USA
J Nucl Med 51:31-6. 2010..We have developed an in vivo method to quantify antibody uptake using (111)In-capromab pendetide SPECT combined with CT (SPECT/CT). Our goal was to evaluate this method for potential grading of prostate tumors...
UroVysion testing can lead to early identification of intravesical therapy failure in patients with high risk non-muscle invasive bladder cancerJared M Whitson
Department of Urology, University of California San Francisco, San Francisco, California, USA
Int Braz J Urol 35:664-70; discussion 671-2. 2009..In this study, we investigated the ability of UroVysion to assess response to intravesical therapy in patients with high risk superficial bladder tumors...
Active surveillance for localized prostate cancer--current practices and recommendationsJennifer N Wu
Department of Urology, University of California, Davis Medical Center, Sacramento, CA, USA
ScientificWorldJournal 10:2352-61. 2010..Ongoing clinical trials with watchful waiting and active surveillance for prostate cancer will ultimately provide improved evidence for managing early, localized disease...
Sociodemographic predictors of prostate cancer risk category at diagnosis: unique patterns of significant and insignificant diseaseMarc A Dall'Era
Urologic Outcomes Research Group, Department of Urology, University of California San Francisco, San Francisco, California, USA
J Urol 181:1622-7; discussion 1627. 2009..We determined various sociodemographic predictors of prostate cancer risk category at presentation as assessed by serum prostate specific antigen, cancer grade and tumor stage...
Impact of malpractice caps on use and outcomes of radical cystectomy for bladder cancer: data from the surveillance, epidemiology, and end results programBadrinath R Konety
Department of Urology, University of Iowa, Iowa City, USA
J Urol 173:2085-9. 2005..We investigated the effect of caps on the use of and outcomes following aggressive surgical treatment (radical cystectomy) in patients with bladder cancer...
Squamous cell carcinoma of the penis: evaluation of data from the surveillance, epidemiology, and end results programJonathan M Rippentrop
Department of Urology, The University of Iowa, Iowa City 52242-1089, USA
Cancer 101:1357-63. 2004..African-American men presented with a higher stage of disease and statistically significant decreased survival, whereas previously or currently married men presented at an earlier stage of disease and sought more aggressive treatment...
Personality, treatment choice and satisfaction in patients with localized prostate cancerCraig A Block
Department of Urology, University of Iowa, Iowa City, IA, USA
Int J Urol 14:1013-8. 2007..We studied whether patient personality influences treatment choice and overall treatment satisfaction...
18F-FDG PET/CT of transitional cell carcinomaVivek V Patil
Department of Radiology, University of California San Francisco, San Francisco, CA 94143 0628, USA
AJR Am J Roentgenol 193:W497-504. 2009..PET/CT may also be helpful in the detection of disease outside the bladder at nodal or more distant sites and in the assessment of recurrent disease...
Bladder cancer incidence and risk factors in men with prostate cancer: results from Cancer of the Prostate Strategic Urologic Research EndeavorStephen Boorjian
Department of Urology, New York Presbyterian Hospital Weill Cornell Medical Center, New York, New York, USA
J Urol 177:883-7; discussion 887-8. 2007..We evaluated a large disease registry to determine the incidence of bladder cancer in patients with prostate cancer and investigate whether the type of treatment for prostate cancer increased the risk of bladder cancer...
Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results Program data baseBadrinath R Konety
Department of Urology, University of Iowa, Iowa City, USA
J Urol 169:946-50. 2003....
Contemporary management of muscle-invasive bladder cancerMarc A Dall'Era
Department of Urology, University of California Davis, 4860 Y Street, Suite 3500, Sacramento, CA 95817, USA
Expert Rev Anticancer Ther 12:941-50. 2012..Personalized chemotherapy is currently being actively pursued to target the underlying molecular changes and tailor to individual needs...
The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancerNecole M Streeper
Department of Urology, University of Iowa, Iowa City, IA 52242 1089, USA
BJU Int 103:475-9. 2009....
The impact of marriage on bladder cancer mortalityJason L Nelles
Department of Urology, School of Medicine, University of California San Francisco, San Francisco, CA 94143, USA
Urol Oncol 27:263-7. 2009..We examined data from the Surveillance, Epidemiology, and End Results (SEER) cancer survival database to see if married patients with bladder cancer had a survival advantage vs. nonmarried patients...
Management of localized prostate cancer in men over 65 yearsMatthew R Cooperberg
Department of Urology, University of California, San Francisco, CA 94143 1695, USA
Curr Opin Urol 19:309-14. 2009..However, the majority of tumors are still detected among men over 65-years-old. The appropriate management of localized disease among these older men is controversial...
Prevalence of prostate specific antigen testing for prostate cancer in elderly menDamon J Dyche
Department of Urology, University of Iowa, Iowa City, Iowa 52242, USA
J Urol 175:2078-82. 2006..The establishment of firm guideline recommendations regarding PSA testing and further evaluation for prostate cancer in elderly men, perhaps based on individualized geriatric assessment, may be helpful...
Two-surgeon versus single-surgeon radical cystectomy and urinary diversion: impact on patient outcomes and costsAaron T Ludwig
Department of Urology, University of Iowa College of Medicine, Iowa City, Iowa 52242-1089, USA
Urology 65:488-92. 2005..Additional reductions in hospital charges could offset the greater physician charges in the NBL patients and allow full realization of the benefit from the shorter operative time with the two-surgeon team...
Prostate-specific antigen testing in the elderly: a hard habit to kick?Badrinath R Konety
Department of Urology, University of Iowa, Iowa City, IA 52246, USA
BJU Int 97:4-5. 2006
Impact of hospital and surgeon volume on in-hospital mortality from radical cystectomy: data from the health care utilization projectBadrinath R Konety
Department of Urology, University of Iowa, Iowa City, Iowa, USA
J Urol 173:1695-700. 2005..We determined the influence of hospital and surgeon volume on various outcome parameters after radical cystectomy for bladder cancer...
Feasibility of radical prostatectomy after neoadjuvant chemohormonal therapy for patients with high risk or locally advanced prostate cancer: results of a phase I/II studyBadrinath R Konety
Department of Urology, Memorial Sloan-Kettering Cancer Center and Cornell University, New York, New York 10021, USA
J Urol 171:709-13. 2004..Positive surgical margin rates are low. This approach yielded good local control of disease, however impact on tumor recurrence and survival is not known...
Contemporary management of superficial bladder cancer in the United States: a pattern of care analysisFadi N Joudi
Department of Urology, University of Iowa, Iowa City 52242-1089, USA
Urology 62:1083-8. 2003..However, 81% of surveyed urologists were still reluctant to refer patients with high-grade Ta-T1 disease with failure after intravesical immunotherapy twice for more aggressive therapy such as cystectomy or radiotherapy...
Influence of post-cystectomy complications on cost and subsequent outcomeBadrinath R Konety
Department of Urology, University of California San Francisco, San Francisco, California 94143 1695, USA
J Urol 177:280-7; discussion 287. 2007..We quantified the impact of specific post-cystectomy complications and combinations thereof in terms of mortality, charges and length of stay...
Factors influencing aggressive therapy for bladder cancer: an analysis of data from the SEER programBadrinath R Konety
Department of Urology, University of Iowa, 200 Hawkins Drive, 3267 RCP, Iowa City, IA 52242 1089, USA
J Urol 170:1765-71. 2003..We also examined the correlation between these factors and disease specific survival such aggressive therapy...
Outcomes and follow-up strategies for patients on active surveillanceMarc A Dall'Era
Department of Urology, University of California, Davis, CA, USA
Curr Opin Urol 19:258-62. 2009..This approach allows one to limit prostate cancer treatment and any risk of related morbidity to the men who will benefit the most from active intervention...
Is the complication rate of radical cystectomy predictive of the complication rate of other urological procedures?Vincent Fradet
Department of Urology and Epidemiology, University of California San Francisco, San Francisco, California, USA
J Urol 181:1054-9; discussion 1059-60. 2009..We hypothesized that the hospital volume of radical cystectomy is an important predictor of complications of other urological procedures...
Effect of postcystectomy infectious complications on cost, length of stay, and mortalityBenjamin J Davies
Department of Urology, University of California, San Francisco, USA
Urology 73:598-602. 2009..The economic and clinical effects of infectious complications after radical cystectomy have not been analyzed...
Phase I clinical trial of an adenovirus/prostate-specific antigen vaccine for prostate cancer: safety and immunologic resultsDavid M Lubaroff
Department of Urology, University of Iowa, Iowa City, Iowa 52242, USA
Clin Cancer Res 15:7375-80. 2009..We performed a phase I clinical trial of adenovirus/prostate-specific antigen (PSA) vaccine in men with measurable metastatic hormone-refractory disease...
Superficial transitional (Ta/T1/CIS) cell carcinoma of the bladderBadrinath R Konety
Department of Urology, University of Iowa, Iowa City, 52242, USA
BJU Int 94:18-21. 2004
Estimating postoperative mortality and morbidity risk of radical cystectomy with continent diversion using predictor equationsMarc C Smaldone
Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15232, USA
J Urol 182:2619-24. 2009..We tested the validity of POSSUM and Portsmouth POSSUM in patients undergoing radical cystectomy with continent diversion...
Long-term treatment of metastatic renal-cell carcinoma with fluorouracilDavid A Anderson
Department of Urology, University of Iowa, Iowa City 52242-1089, USA
Lancet Oncol 5:690-2. 2004
Trends in regionalization of inpatient care for urological malignancies, 1988 to 2002Matthew R Cooperberg
Urologic Outcomes Research Group, Program in Urologic Oncology, Department of Urology, University of California San Francisco Comprehensive Cancer Center, California 94115 1711, USA
J Urol 178:2103-8; discussion 2108. 2007..The net effect of these pressures may be the regionalization of care. We quantified trends in the regionalization of inpatient care for urological oncology in a national administrative database...
Fluorescence cystoscopy and bladder surveillanceFadi N Joudi
Department of Urology, University of Iowa, 200 Hawkins Drive, Iowa City, IA 52241, USA
Curr Opin Urol 14:265-70. 2004..These agents need to be studied in large randomized trials to prove that using these agents can facilitate early diagnosis and improved prognosis in patients with bladder cancer...
Evaluation of intraprostatic metabolism of 1,25-dihydroxyvitamin D(3) (calcitriol) using a microdialysis techniqueBadrinath R Konety
Department of Urology, University of Iowa, Iowa City, USA
Urology 59:947-52. 2002..This technique could be used to determine the tissue levels of calcitriol more accurately and to conduct additional studies to better elucidate the effects of castration on the intraprostatic pharmacokinetics of calcitriol...
Quality of life in long-term survivors of bladder cancerVeerasathpurush Allareddy
Department of Urology, University of Iowa, Iowa City, Iowa 52242-1089, USA
Cancer 106:2355-62. 2006..Long-term QOL declines even in those with intact bladders, particularly in those with comorbidities...
Functional characterization of the bladder cancer marker, BLCA-4Thu-Suong Van Le
Department of Urology, University of Pittsburgh and University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania 15232, USA
Clin Cancer Res 10:1384-91. 2004..It appears to be a transcription factor that may play a role in the regulation of the gene expression in bladder cancer. BLCA-4 is a marker with significant clinical utility that may have an active role in the disease...
Testicular recurrence from "primary" retroperitoneal germ cell tumorSteven R Mindrup
Department of Urology, University of Iowa School of Medicine, Iowa City, Iowa 52242-1089, USA
Urology 64:1031. 2004..This presents an interesting dilemma as to whether this was recurrence of the original tumor or a new, primary tumor. The patient's outcome and surveillance protocol for these tumors are presented...
Effect of a minimum lymph node policy in radical cystectomy and pelvic lymphadenectomy on lymph node yields, lymph node positivity rates, lymph node density, and survivorship in patients with bladder cancerAndrea C Fang
Department of Urology, Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California, USA
Cancer 116:1901-8. 2010..Lymph node counts are often a proxy for the extensiveness of a dissection. In the current study, the impact of an institutional policy requiring a minimum number of lymph nodes was assessed...
The prevalence of renal cell carcinoma diagnosed at autopsySteven R Mindrup
Department of Urology, University of Iowa, 200 Hawkins Drive, 3 RCP, Iowa City, IA 52242-1089, USA
BJU Int 95:31-3. 2005..However, the rate of occult kidney cancer per 100 autopsies did not change significantly between the two periods, suggesting a true increase in the frequency of clinically detected kidney cancer...
Surgical enucleation for the treatment of renal tumorsMichael E Franks
Department of Urology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
Urol Int 71:184-9. 2003..Manual compression of the kidney appears to be at least as effective as clamping of the renal vessels in obtaining vascular control during the procedure and is more expeditious...
Complete response of bony metastatic bladder urothelial cancer to neoadjuvant chemotherapy and cystectomyFadi N Joudi
Department of Urology, University of Iowa, Iowa City, IA 52242 1089, USA
Urol Oncol 24:403-6. 2006..The patient continues to be without evidence of disease 2 years postoperatively. This case shows that neoadjuvant chemotherapy with nonstandard regimens can yield responses in patients with bone metastases...
High prevalence of screening-detected prostate cancer among Afro-Caribbeans: the Tobago Prostate Cancer SurveyClareann H Bunker
Department of Epidemiology, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, USA
Cancer Epidemiol Biomarkers Prev 11:726-9. 2002..These data support the hypothesis that populations of African descent share genetic and/or lifestyle factors that contribute to their elevated risk for prostate cancer...
Impact of extent of lymphadenectomy on survival after radical prostatectomy for prostate cancerSue A Joslyn
Division of Health Promotion and Education, University of Northern Iowa, Cedar Falls, Iowa, USA
Urology 68:121-5. 2006..CONCLUSIONS: Performing more extensive pelvic lymphadenectomy in patients undergoing radical prostatectomy could improve the accuracy of staging and reduce the risk of prostate cancer-specific death in the long term...
Prostate cancer screening parameters in a high-risk African-Caribbean populationClareann H Bunker
Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania 15261, USA
Urology 63:737-41. 2004..The screening was highly efficacious, with a positive predictive value of 56% for an elevated PSA level and 40% for an elevated PSA level and/or abnormal DRE findings...
Characteristics of patients and predictors of in-hospital mortality after hospitalization for head and neck cancersVeerasathpurush Allareddy
Department of Health Management and Policy, University of Iowa, Iowa City, Iowa 52242, USA
Cancer 106:2382-8. 2006..The objectives of this study were to describe the characteristics of patients who were hospitalized for head and neck cancer (HNC) during the years 2000 through 2003 and to identify predictors of in-hospital mortality...
The impact of provider volume on outcomes from urological cancer therapyFadi N Joudi
University of Iowa Department of Urology, Iowa City, Iowa 52242, USA
J Urol 174:432-8. 2005..An alternative would be to attempt to improve outcomes at low volume hospitals by identifying drivers of high quality care at high volume hospitals and transferring some of these characteristics...
Sickness and survival in bladder cancer: is comorbidity the crystal ball?Badrinath R Konety
Eur Urol 53:465-7. 2008
Impact of lymphadenectomy and nodal burden in renal cell carcinoma: retrospective analysis of the National Surveillance, Epidemiology, and End Results databaseSue A Joslyn
Division of Health Promotion and Education, University of Northern Iowa, Cedar Falls, Iowa, USA
Urology 65:675-80. 2005..An increased number of positive nodes, as well as an increasing nodal burden, although associated with a lower likelihood of survival, were not independent predictors of RCC-specific mortality...
Vitamin D and prostate cancerBadrinath R Konety
Departments of Urology, Pathology, and Pharmacology, University of Pittsburgh, 5200 Centre Avenue, G-40, Pittsburgh, PA 15232, USA
Urol Clin North Am 29:95-106, ix. 2002..There is now considerable evidence suggesting a role for vitamin D in prostate cancer. In this article, we have reviewed the current evidence supporting the use of vitamin D in the prevention and treatment of prostate cancer...
Effect of axillary lymphadenectomy on breast carcinoma survivalSue A Joslyn
University of Northern Iowa, 221 WRC, Cedar Falls, IA 50614 0241, USA
Breast Cancer Res Treat 91:11-8. 2005..To determine the effect of axillary lymphadenectomy on breast carcinoma survival, and to determine racial and age differences in the extent of axillary lymphadenectomy...
Molecular markers in bladder cancer: a critical appraisalBadrinath R Konety
Department of Urology, University of Iowa, Iowa City, IA 52242, USA
Urol Oncol 24:326-37. 2006..Further studies involving larger numbers of patients are required to determine their accuracy and widespread applicability in guiding treatment of bladder cancer...
Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathwayShinji Urakami
Department of Urology 112F, Veterans Affairs Medical Center, and University of California at San Francisco, 4150 Clement Street, San Francisco, CA 94121, USA
Clin Cancer Res 12:383-91. 2006..Wnt inhibitory factor-1 (Wif-1) was identified as one of the secreted antagonists that can bind Wnt protein. We hypothesize that Wif-1 plays an important role in bladder cancer pathogenesis...
Specificity of procedure volume and in-hospital mortality associationVeerajalandhar Allareddy
Department of Internal Medicine and Pediatrics, MetroHealth Medical Center, Cleveland, OH, USA
Ann Surg 246:135-9. 2007....
A delay in radical cystectomy of >3 months is not associated with a worse clinical outcomeVincent Fradet
BJU Int 101:257-8; author reply 258-9. 2008
Association between volume and charges for most frequently performed ambulatory and nonambulatory surgery for bladder cancer. Is more cheaper?Badrinath R Konety
Departments of Urology, University of Iowa, 200 Hawkins Drive, 3RCP, Iowa City, Iowa 52242 1089, USA
J Urol 172:1056-61. 2004..We investigated the relationship between provider volume and charges for transurethral bladder tumor resection (TURBT) and radical cystectomy in patients with bladder cancer...
Commentary on the etiologic relationship between prostate radiation and bladder cancer: the scourge for one is poison for the otherBadrinath R Konety
J Urol 179:S12-3. 2008
